Fabien Dutheil*, Youssef Slama
Androgen deprivation is a key treatment in the management of patient with locally advanced and metastatic prostate cancer. A better comprehension of the castration resistance's mechanisms allowed the development of second-generation hormonal therapies that are generally better tolerated than chemotherapy and can improve the survival and quality of life of patients with prostate cancer.
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi